|
1
|
Echouffo-Tcheugui JB and Dagogo-Jack S:
Preventing diabetes mellitus in developing countries. Nat Rev
Endocrinol. 8:557–562. 2012. View Article : Google Scholar
|
|
2
|
Lotfy M, Adeghate J, Kalasz H, Singh J and
Adeghate E: Chronic complications of diabetes mellitus: A mini
review. Curr Diabetes Rev. 13:3–10. 2017. View Article : Google Scholar
|
|
3
|
Boudina S and Abel ED: Diabetic
cardiomyopathy revisited. Circulation. 115:3213–3223. 2007.
View Article : Google Scholar
|
|
4
|
Westermeier F, Riquelme JA, Pavez M,
Garrido V, Díaz A, Verdejo HE, Castro PF, García L and Lavandero S:
New molecular insights of insulin in diabetic cardiomyopathy. Front
Physiol. 7:1252016. View Article : Google Scholar :
|
|
5
|
Travers JG, Kamal FA, Robbins J, Yutzey KE
and Blaxall BC: Cardiac fibrosis: The fibroblast awakens. Circ Res.
118:1021–1040. 2016. View Article : Google Scholar :
|
|
6
|
Xu F, Liu C, Zhou D and Zhang L:
TGF-beta/SMAD pathway and its regulation in hepatic fibrosis. J
Histochem Cytochem. 64:157–167. 2016. View Article : Google Scholar :
|
|
7
|
Song SE, Kim YW, Kim JY, Lee DH, Kim JR
and Park SY: IGFBP5 mediates high glucose-induced cardiac
fibroblast activation. J Mol Endocrinol. 50:291–303. 2013.
View Article : Google Scholar
|
|
8
|
Liu ZW, Wang JK, Qiu C, Guan GC, Liu XH,
Li SJ and Deng ZR: Matrine pretreatment improves cardiac function
in rats with diabetic cardiomyopathy via suppressing ROS/TLR-4
signaling pathway. Acta Pharmacol Sin. 36:323–333. 2015. View Article : Google Scholar :
|
|
9
|
Gao HY, Li GY, Lou MM, Li XY, Wei XY and
Wang JH: Hepatoprotective effect of Matrine salvianolic acid B salt
on carbon tetrachloride-induced hepatic fibrosis. J Inflamm (Lond).
9:162012. View Article : Google Scholar :
|
|
10
|
Liu Z, Zhao N, Zhu H, Zhu S, Pan S, Xu J,
Zhang X, Zhang Y and Wang J: Circulating interleukin-1β promotes
endoplasmic reticulum stress-induced myocytes apoptosis in diabetic
cardiomyopathy via interleukin-1 receptor-associated kinase-2.
Cardiovasc Diabetol. 14:1252015. View Article : Google Scholar :
|
|
11
|
Liu Z, Cai H, Zhu H, Toque H, Zhao N, Qiu
C, Guan G, Dang Y and Wang J: Protein kinase RNA-like endoplasmic
reticulum kinase (PERK)/calcineurin signaling is a novel pathway
regulating intracellular calcium accumulation which might be
involved in ventricular arrhythmias in diabetic cardiomyopathy.
Cell Signal. 26:2591–2600. 2014. View Article : Google Scholar
|
|
12
|
Li R, Xiao J, Qing X, Xing J, Xia Y, Qi J,
Liu X, Zhang S, Sheng X, Zhang X and Ji X: Sp1 mediates a
therapeutic role of miR-7a/b in angiotensin II-induced cardiac
fibrosis via mechanism involving the Tgf-β and mapks pathways in
cardiac fibroblasts. PLoS One. 10:e01255132015. View Article : Google Scholar :
|
|
13
|
Adeghate E: Molecular and cellular basis
of the aetiology and management of diabetic cardiomyopathy: A short
review. Mol Cell Biochem. 261:187–191. 2004. View Article : Google Scholar
|
|
14
|
Stratmann B, Worms J and Tschoepe D:
Diabetic cardiomyopathy/heart failure: News regarding etiology,
diagnosis, therapy. Dtsch Med Wochenschr. 139:2006–2009. 2014.(In
German).
|
|
15
|
Fan D, Takawale A, Lee J and Kassiri Z:
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling
in heart disease. Fibrogenesis Tissue Repair. 5:152012. View Article : Google Scholar :
|
|
16
|
Xie Y, Liao J, Li M, Wang X, Yang Y, Ge J,
Chen R and Chen H: Impaired cardiac microvascular endothelial cells
function induced by Coxsackievirus B3 infection and its potential
role in cardiac fibrosis. Virus Res. 169:188–194. 2012. View Article : Google Scholar
|
|
17
|
Cavalera M, Wang J and Frangogiannis NG:
Obesity, metabolic dysfunction, and cardiac fibrosis:
Pathophysiological pathways, molecular mechanisms and therapeutic
opportunities. Transl Res. 164:323–335. 2014. View Article : Google Scholar :
|
|
18
|
Russo I and Frangogiannis NG:
Diabetes-associated cardiac fibrosis: Cellular effectors, molecular
mechanisms and therapeutic opportunities. J Mol Cell Cardiol.
90:84–93. 2016. View Article : Google Scholar
|
|
19
|
Hutchinson KR, Lord CK, West TA and
Stewart JA Jr: Cardiac fibroblast-dependent extracellular matrix
accumulation is associated with diastolic stiffness in type 2
diabetes. PLoS One. 8:e720802013. View Article : Google Scholar :
|
|
20
|
Chen M, Li H, Wang G, Shen X, Zhao S and
Su W: Atorvastatin prevents advanced glycation end products
(AGEs)-induced cardiac fibrosis via activating peroxisome
proliferator-activated receptor gamma (PPAR-γ). Metabolism.
65:441–453. 2016. View Article : Google Scholar
|
|
21
|
Bos R, Mougenot N, Findji L, Médiani O,
Vanhoutte PM and Lechat P: Inhibition of catecholamine-induced
cardiac fibrosis by an aldosterone antagonist. J Cardiovasc
Pharmacol. 45:8–13. 2005. View Article : Google Scholar
|
|
22
|
Liang M, Woodard LE, Liang A, Luo J,
Wilson MH, Mitch WE and Cheng J: Protective role of insulin-like
growth factor-1 receptor in endothelial cells against unilateral
ureteral obstruction-induced renal fibrosis. Am J Pathol.
185:1234–1250. 2015. View Article : Google Scholar :
|
|
23
|
Li FZ, Cai PC, Song LJ, Zhou LL, Zhang Q,
Rao SS, Xia Y, Xiang F, Xin JB, Greer PA, et al: Crosstalk between
calpain activation and TGF-β1 augments collagen-I synthesis in
pulmonary fibrosis. Biochim Biophys Acta. 1852:1796–1804. 2015.
View Article : Google Scholar
|
|
24
|
Cutroneo KR, White SL, Phan SH and Ehrlich
HP: Therapies for bleomycin induced lung fibrosis through
regulation of TGF-beta1 induced collagen gene expression. J Cell
Physiol. 211:585–589. 2007. View Article : Google Scholar
|
|
25
|
Meng XM, Tang PM, Li J and Lan HY:
TGF-β/Smad signaling in renal fibrosis. Front Physiol. 6:822015.
View Article : Google Scholar :
|
|
26
|
Zeglinski MR, Hnatowich M, Jassal DS and
Dixon IM: SnoN as a novel negative regulator of TGF-β/Smad
signaling: A target for tailoring organ fibrosis. Am J Physiol
Heart Circ Physiol. 308:H75–H82. 2015. View Article : Google Scholar
|
|
27
|
Tasanarong A, Kongkham S, Duangchana S,
Thitiarchakul S and Eiam-Ong S: Vitamin E ameliorates renal
fibrosis by inhibition of TGF-beta/Smad2/3 signaling pathway in UUO
mice. J Med Assoc Thai. 94 Suppl 7:S1–S9. 2011.
|
|
28
|
Huang J and Xu H: Matrine: Bioactivities
and structural modifications. Curr Top Med Chem. 16:3365–3378.
2016. View Article : Google Scholar
|
|
29
|
Yu JL, Li JH, Chengz RG, Ma YM, Wang XJ
and Liu JC: Effect of matrine on transforming growth factor β1 and
hepatocyte growth factor in rat liver fibrosis model. Asian Pac J
Trop Med. 7:390–393. 2014. View Article : Google Scholar
|
|
30
|
Yu J, Yang S, Wang X and Gan R: Matrine
improved the function of heart failure in rats via inhibiting
apoptosis and blocking β3adrenoreceptor/endothelial nitric oxide
synthase pathway. Mol Med Rep. 10:3199–3204. 2014. View Article : Google Scholar
|
|
31
|
Zhang L, Zhang H, Zhu Z, Lu X, Zhou M, Sun
X, He L, Bai Y and Ma L: Matrine regulates immune functions to
inhibit the proliferation of leukemic cells. Int J Clin Exp Med.
8:5591–5600. 2015.
|
|
32
|
Lei B, Hitomi H, Mori T, Nagai Y, Deguchi
K, Mori H, Masaki T, Nakano D, Kobori H, Kitaura Y and Nishiyama A:
Effect of efonidipine on TGF-β1-induced cardiac fibrosis through
Smad2-dependent pathway in rat cardiac fibroblasts. J Pharmacol
Sci. 117:98–105. 2011. View Article : Google Scholar :
|
|
33
|
Zhan CY, Tang JH, Zhou DX and Li ZH:
Effects of tanshinone IIA on the transforming growth factor
β1/Smadsignaling pathway in rat cardiac fibroblasts. Indian J
Pharmacol. 46:633–638. 2014. View Article : Google Scholar :
|
